$EXE
EXPAND ENERGY Corp

2024 Q3 Form 10-Q Financial Statement

#000089512624000108 Filed on July 29, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $648.0M $505.0M
YoY Change -57.14% -64.41%
Cost Of Revenue $221.0M
YoY Change -34.23%
Gross Profit $282.0M
YoY Change -73.96%
Gross Profit Margin 55.84%
Selling, General & Admin $188.0M
YoY Change -70.72%
% of Gross Profit 66.67%
Research & Development $3.000M
YoY Change -62.5%
% of Gross Profit 1.06%
Depreciation & Amortization $335.0M $348.0M
YoY Change -12.3% -7.45%
% of Gross Profit 123.4%
Operating Expenses $555.0M
YoY Change -46.38%
Operating Profit -$155.0M -$294.0M
YoY Change -296.2% -712.5%
Interest Expense -$20.00M
YoY Change -9.09%
% of Operating Profit
Other Income/Expense, Net -$3.000M -$1.000M
YoY Change -62.5% -104.35%
Pretax Income -$158.0M -$295.0M
YoY Change -322.54% -156.95%
Income Tax -$44.00M -$68.00M
% Of Pretax Income
Net Earnings -$114.0M -$227.0M
YoY Change -262.86% -158.06%
Net Earnings / Revenue -17.59% -44.95%
Basic Earnings Per Share -$0.85 -$1.73
Diluted Earnings Per Share -$0.85 -$1.73
COMMON SHARES
Basic Shares Outstanding 131.3M shares 131.0M shares
Diluted Shares Outstanding 133.8M shares 131.2M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.019B
YoY Change 12.85%
Cash & Equivalents $1.044B $1.019B
Short-Term Investments
Other Short-Term Assets $217.0M $207.0M
YoY Change 33.13% -67.96%
Inventory
Prepaid Expenses
Receivables $261.0M $350.0M
Other Receivables $128.0M
Total Short-Term Assets $1.797B $2.013B
YoY Change -28.55% -9.32%
LONG-TERM ASSETS
Property, Plant & Equipment $9.954B $10.00B
YoY Change -1.5% -6.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $588.0M $577.0M
YoY Change 4.07% -62.92%
Total Long-Term Assets $11.60B $11.60B
YoY Change -1.18% -5.03%
TOTAL ASSETS
Total Short-Term Assets $1.797B $2.013B
Total Long-Term Assets $11.60B $11.60B
Total Assets $13.39B $13.61B
YoY Change -6.01% -5.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $264.0M $274.0M
YoY Change -51.11% -57.32%
Accrued Expenses $132.0M $140.0M
YoY Change -31.96% -74.77%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $899.0M $931.0M
YoY Change -44.3% -43.61%
LONG-TERM LIABILITIES
Long-Term Debt $2.017B $2.021B
YoY Change -0.74% -0.74%
Other Long-Term Liabilities $17.00M $19.00M
YoY Change -19.05% -94.51%
Total Long-Term Liabilities $2.034B $2.040B
YoY Change -0.93% -14.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $899.0M $931.0M
Total Long-Term Liabilities $2.034B $2.040B
Total Liabilities $3.204B $3.238B
YoY Change -19.5% -19.71%
SHAREHOLDERS EQUITY
Retained Earnings $4.409B $4.601B
YoY Change -2.71% -1.46%
Common Stock $1.000M $1.000M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.19B $10.37B
YoY Change
Total Liabilities & Shareholders Equity $13.39B $13.61B
YoY Change -6.01% -5.69%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$114.0M -$227.0M
YoY Change -262.86% -158.06%
Depreciation, Depletion And Amortization $335.0M $348.0M
YoY Change -12.3% -7.45%
Cash From Operating Activities $209.0M
YoY Change -59.42%
INVESTING ACTIVITIES
Capital Expenditures $302.0M
YoY Change -43.02%
Acquisitions
YoY Change
Other Investing Activities $36.00M
YoY Change -96.34%
Cash From Investing Activities -$266.0M
YoY Change -158.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -102.0M
YoY Change -46.32%
NET CHANGE
Cash From Operating Activities 209.0M
Cash From Investing Activities -266.0M
Cash From Financing Activities -102.0M
Net Change In Cash -159.0M
YoY Change -120.44%
FREE CASH FLOW
Cash From Operating Activities $209.0M
Capital Expenditures $302.0M
Free Cash Flow -$93.00M
YoY Change 520.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-227000000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-227000000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
10729000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-201000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-201000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1780000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1780000000 usd
chk Cash Received Paid On Derivative Settlements
CashReceivedPaidOnDerivativeSettlements
488000000 usd
chk Cash Received Paid On Derivative Settlements
CashReceivedPaidOnDerivativeSettlements
-49000000 usd
chk Receipts Of Deferred Consideration
ReceiptsOfDeferredConsideration
116000000 usd
chk Receipts Of Deferred Consideration
ReceiptsOfDeferredConsideration
0 usd
chk Funds Held For Transition Services
FundsHeldForTransitionServices
0 usd
chk Funds Held For Transition Services
FundsHeldForTransitionServices
97000000 usd
chk Operating Lease Liability Recognized
OperatingLeaseLiabilityRecognized
0 usd
chk Operating Lease Liability Recognized
OperatingLeaseLiabilityRecognized
65000000 usd
CY2023Q1 chk Adjustments To Additional Paid In Capital Warrant Exercise
AdjustmentsToAdditionalPaidInCapitalWarrantExercise
0 usd
CY2023Q2 chk Adjustments To Additional Paid In Capital Warrant Exercise
AdjustmentsToAdditionalPaidInCapitalWarrantExercise
0 usd
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4000000 usd
CY2024Q1 chk Adjustments To Additional Paid In Capital Warrant Exercise
AdjustmentsToAdditionalPaidInCapitalWarrantExercise
0 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
26000000 usd
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
77000000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
10682000000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
9000000 usd
CY2024Q2 chk Adjustments To Additional Paid In Capital Warrant Exercise
AdjustmentsToAdditionalPaidInCapitalWarrantExercise
1000000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-227000000 usd
CY2024Q2 us-gaap Dividends Common Stock
DividendsCommonStock
95000000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
10370000000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
76000000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-227000000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-227000000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
391000000 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
391000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-201000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-201000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1780000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1780000000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131168000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
133514000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131030000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
134125000 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
9497000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
9529000 shares
CY2024Q2 chk Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Restricted Stock Units
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfRestrictedStockUnits
0 shares
CY2023Q2 chk Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Restricted Stock Units
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfRestrictedStockUnits
208000 shares
chk Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Restricted Stock Units
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfRestrictedStockUnits
0 shares
chk Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Restricted Stock Units
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfRestrictedStockUnits
306000 shares
CY2024Q2 chk Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Performance Share Units
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfPerformanceShareUnits
0 shares
CY2023Q2 chk Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Performance Share Units
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfPerformanceShareUnits
48000 shares
chk Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Performance Share Units
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfPerformanceShareUnits
0 shares
chk Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Performance Share Units
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfPerformanceShareUnits
47000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131168000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143267000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131030000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
144007000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.73
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.93
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.53
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
13.27
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.73
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.73
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.53
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
12.36
CY2024Q2 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
76000000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
83000000 usd
CY2024Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
5000000 usd
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
5000000 usd
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2021000000 usd
CY2024Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
1941000000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2028000000 usd
CY2023Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
1943000000 usd
CY2024Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
265000000 usd
CY2023Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
360000000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
140000000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
211000000 usd
CY2024Q2 us-gaap Hedging Liabilities Current
HedgingLiabilitiesCurrent
0 usd
CY2023Q4 us-gaap Hedging Liabilities Current
HedgingLiabilitiesCurrent
2000000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
45000000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
64000000 usd
CY2024Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
54000000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
84000000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
48000000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
84000000 usd
CY2024Q2 chk Joint Interest Advances Current
JointInterestAdvancesCurrent
4000000 usd
CY2023Q4 chk Joint Interest Advances Current
JointInterestAdvancesCurrent
8000000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
55000000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
34000000 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
611000000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
847000000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1000000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
350000000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
593000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-262000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2311000000 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
chk Effective Income Tax Rate Current Tax Expense
EffectiveIncomeTaxRateCurrentTaxExpense
0
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
132000000 usd
chk Effective Income Tax Rate Current Tax Expense
EffectiveIncomeTaxRateCurrentTaxExpense
0.057
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-61000000 usd
chk Effective Income Tax Rate Deferred Tax Expense
EffectiveIncomeTaxRateDeferredTaxExpense
0.233
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
399000000 usd
chk Effective Income Tax Rate Deferred Tax Expense
EffectiveIncomeTaxRateDeferredTaxExpense
0.173
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-61000000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.233
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
531000000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.230
chk Estimated Effective Income Tax Rate Percent
EstimatedEffectiveIncomeTaxRatePercent
0.224
chk Estimated Effective Income Tax Rate Percent
EstimatedEffectiveIncomeTaxRatePercent
0.230
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
132000000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
12000000 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
14000000 usd
CY2024Q1 chk Common Stock Dividends Per Share Paid Base
CommonStockDividendsPerSharePaidBase
0.575
CY2024Q1 chk Common Stock Dividends Per Share Paid Variable
CommonStockDividendsPerSharePaidVariable
0
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.575
CY2024Q1 us-gaap Dividends
Dividends
77000000 usd
CY2024Q2 chk Common Stock Dividends Per Share Paid Base
CommonStockDividendsPerSharePaidBase
0.575
CY2024Q2 chk Common Stock Dividends Per Share Paid Variable
CommonStockDividendsPerSharePaidVariable
0.14
CY2024Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.715
CY2024Q2 us-gaap Dividends
Dividends
95000000 usd
CY2023Q1 chk Common Stock Dividends Per Share Paid Base
CommonStockDividendsPerSharePaidBase
0.55
CY2023Q1 chk Common Stock Dividends Per Share Paid Variable
CommonStockDividendsPerSharePaidVariable
0.74
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.29
CY2023Q1 us-gaap Dividends
Dividends
175000000 usd
CY2023Q2 chk Common Stock Dividends Per Share Paid Base
CommonStockDividendsPerSharePaidBase
0.55
CY2023Q2 chk Common Stock Dividends Per Share Paid Variable
CommonStockDividendsPerSharePaidVariable
0.63
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.18
CY2023Q2 us-gaap Dividends
Dividends
160000000 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2024Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21000000 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19000000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
7000000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3000000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
9000000 usd
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4000000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
21000000 usd
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000895126-24-000108-index-headers.html Edgar Link pending
0000895126-24-000108-index.html Edgar Link pending
0000895126-24-000108.txt Edgar Link pending
0000895126-24-000108-xbrl.zip Edgar Link pending
chk-20240630.htm Edgar Link pending
chk-20240630.xsd Edgar Link pending
chk-20240630_g1.jpg Edgar Link pending
chk-ex_101x20240630x10q.htm Edgar Link pending
chk-ex_311x20240630x10q.htm Edgar Link pending
chk-ex_312x20240630x10q.htm Edgar Link pending
chk-ex_321x20240630x10q.htm Edgar Link pending
chk-ex_322x20240630x10q.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
chk-20240630_cal.xml Edgar Link unprocessable
chk-20240630_def.xml Edgar Link unprocessable
chk-20240630_lab.xml Edgar Link unprocessable
chk-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
chk-20240630_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending